ViaDerma (VDRM) Short Interest Ratio & Short Volume $0.0070 +0.01 (+1,300.00%) As of 03:40 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartShort InterestBuy This Stock ViaDerma Short Interest DataViaDerma (VDRM) has a short interest of 12,400 shares. This marks a -86.08% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 1.55 million shares to cover all short positions.Current Short Interest12,400 sharesPrevious Short Interest89,100 sharesChange Vs. Previous Month-86.08%Dollar Volume Sold Short$161.20Short Interest Ratio0.0 Days to CoverLast Record DateFebruary 28, 2025Today's Trading Volume111,011 sharesAverage Trading Volume1,554,718 sharesToday's Volume Vs. Average7% Short Selling ViaDerma? Sign up to receive the latest short interest report for ViaDerma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartVDRM Short Interest Over TimeVDRM Days to Cover Over TimeVDRM Percentage of Float Shorted Over Time ViaDerma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/28/202512,400 shares $161.20 -86.1%N/A0 $0.01 2/15/202589,100 shares $1.35 thousand -10.5%N/A0 $0.02 1/31/202599,600 shares $1.20 thousand -19.9%N/A0 $0.01 1/15/2025124,300 shares $1.32 thousand No ChangeN/A0 $0.01 12/15/202411,100 shares $98.79 +1,287.5%N/A0 $0.01 11/30/2024800 shares $7.52 No ChangeN/A0 $0.01 10/31/202489,900 shares $665.26 No ChangeN/A0 $0.01 8/15/202433,900 shares $162.72 No ChangeN/A0 $0.00 3/15/20244,800 shares $41.76 -92.7%N/A0 $0.01 2/29/202465,800 shares $756.70 -29.6%N/A0 $0.01 Get the Latest News and Ratings for VDRM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ViaDerma and its competitors with MarketBeat's FREE daily newsletter. 2/15/202493,500 shares $850.85 -42.4%N/A0 $0.01 1/15/202414,700 shares $164.64 No ChangeN/A0 $0.01 11/30/202310,000 shares $108.00 No ChangeN/A0 $0.01 10/31/202329,000 shares $348.00 No ChangeN/A0 $0.01 9/30/202335,300 shares $388.30 No ChangeN/A0 $0.01 8/15/202310,000 shares $106.00 -94.3%N/A0 $0.01 7/31/2023173,900 shares $1.81 thousand +11,493.3%N/A0 $0.01 7/15/20231,500 shares $15.15 No ChangeN/A0 $0.01 6/15/202366,600 shares $705.96 No ChangeN/A0.1 $0.01 5/15/2023206,800 shares $2.27 thousand No ChangeN/A0 $0.01 3/15/202348,900 shares $489.00 -93.4%N/A0 $0.01 2/28/2023745,900 shares $4.03 thousand +0.1%N/A0.1 $0.01 2/15/2023745,000 shares $4.62 thousand +2,880.0%N/A0.1 $0.01 1/31/202325,000 shares $165.00 No ChangeN/A0 $0.01 10/15/202215,000 shares $135.00 -70.0%N/A0 $0.01 9/30/202250,000 shares $440.00 No ChangeN/A0 $0.01 8/31/202223,700 shares $272.55 No ChangeN/A0 $0.01 7/15/20225,000 shares $40.00 -90.2%N/A0 $0.01 6/30/202251,100 shares $316.82 No ChangeN/A0 $0.01 5/31/202225,000 shares $160.00 No ChangeN/A0 $0.01 4/15/202289,000 shares $738.70 +3.7%N/A0 $0.01 3/31/202285,800 shares $763.62 +90.7%N/A0 $0.01 3/15/202245,000 shares $315.00 No ChangeN/A0 $0.01 1/15/202216,400 shares $196.80 No ChangeN/A0 $0.01 12/15/202133,800 shares $297.44 -79.1%N/A0 $0.01 11/30/2021161,500 shares $2.26 thousand +1,918.8%N/A0 $0.01 11/15/20218,000 shares $107.20 -97.7%N/A0 $0.01 10/29/2021354,000 shares $5.06 thousand +4,325.0%N/A0.1 $0.01 10/15/20218,000 shares $124.80 -84.0%N/A0 $0.02 9/30/202150,000 shares $720.00 +49,900.0%N/A0 $0.01I warned you about Nvidia… now look what’s happening (Ad)Nvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before the open. That’s the kind of move Tim Sykes built his XGPT system to trade. It scans AI news in real time, filters the noise, and pinpoints when to strike. He’s now showing exactly how it works — before the next headline hits.Watch how Tim Sykes trades AI headlines for real gains 9/15/2021100 shares $1.52 -99.9%N/A0 $0.02 8/31/2021108,800 shares $1.76 thousand +31.1%N/A0 $0.02 8/13/202183,000 shares $2.02 thousand -10.2%N/A0 $0.02 7/30/202192,400 shares $2.15 thousand +13.7%N/A0 $0.02 7/15/202181,300 shares $2.04 thousand +408.1%N/A0 $0.03 6/30/202116,000 shares $448.00 -54.7%N/A0 $0.03 6/15/202135,300 shares $1.11 thousand No ChangeN/A0 $0.03 VDRM Short Interest - Frequently Asked Questions What is ViaDerma's current short interest? Short interest is the volume of ViaDerma shares that have been sold short but have not yet been closed out or covered. As of February 28th, investors have sold 12,400 shares of VDRM short. Learn More on ViaDerma's current short interest. Is ViaDerma's short interest increasing or decreasing? ViaDerma saw a decline in short interest during the month of February. As of February 28th, there was short interest totaling 12,400 shares, a decline of 86.1% from the previous total of 89,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($23.74 billion), iShares 20+ Year Treasury Bond ETF ($10.75 billion), MicroStrategy Incorporated ($6.56 billion), Apollo Global Management Inc. ($5.40 billion), Charter Communications, Inc. ($4.57 billion), AppLovin Corporation ($4.45 billion), Capital One Financial Corporation ($4.33 billion), Super Micro Computer, Inc. ($4.23 billion), Schlumberger Limited ($3.22 billion), and Royal Caribbean Cruises Ltd. ($3.06 billion). View all of the most shorted stocks. What does it mean to sell short ViaDerma stock? Short selling VDRM is an investing strategy that aims to generate trading profit from ViaDerma as its price is falling. VDRM shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ViaDerma? A short squeeze for ViaDerma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VDRM, which in turn drives the price of the stock up even further. How often is ViaDerma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VDRM, twice per month. The most recent reporting period available is February, 28 2025. More Short Interest Resources from MarketBeat Related Companies FFNTF Short Interest Data AGNPF Short Interest Data ALST Short Interest Data ALVOW Short Interest Data ABMC Short Interest Data AOBI Short Interest Data ANTH Short Interest Data AZNCF Short Interest Data AVVH Short Interest Data AXIM Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:VDRM) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredFirst time revealing what I do with my own moneyMy mom has made 3,400% returns - here’s her 3-Stock Secret' Joel Litman is an accountant. So is his mom, wh...Altimetry | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | SponsoredNvidia’s next AI move could catch traders flat-footedTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ViaDerma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ViaDerma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.